Optimization of physicochemical conditions to produce silver nanoparticles and estimation of the biological effects of colloids synthesized

被引:14
作者
Dzhimak S.S. [1 ]
Sokolov M.E. [1 ]
Basov A.A. [2 ]
Fedosov S.R. [1 ]
Malyshko V.V. [2 ]
Vlasov R.V. [1 ]
Lyasota O.M. [1 ]
Baryshev M.G. [1 ]
机构
[1] Kuban State University, Krasnodar
[2] Kuban State Medical University, Krasnodar
来源
Nanotechnologies in Russia | 2016年 / 11卷 / 11-12期
关键词
D O I
10.1134/S1995078016060082
中图分类号
学科分类号
摘要
The results of our study of the size, optical properties, and aggregate stability of silver nanoparticles in aqueous solutions 1, 2, and 12 months after their synthesis are reported. It has been shown that nanoparticles synthesized using a combined application of physical factors, such as ultraviolet radiation, ultrasound, and uniform mixing (providing conditions of isolation from the atmospheric air) are smaller in size (from 1 to 10 nm) and have more homogenous distribution of the diameter of nanoparticles. A lower aggregation has been noted compared with particles prepared without observing the synthesis algorithm that was developed and conditions given above. The results of studying antimicrobial antiseptic properties based on a colloidal nanosilver solution prepared using the technology of diffusion-cavitation photochemical reduction of silver nitrate are also reported. A high antimicrobial activity of the resulting colloidal solution with silver nanoparticles against clinical isolates of P. aeruginosa, A. baumanii, and E. coli has been demonstrated as compared with the original silver nitrate and the ligand (polyvinylpyrrolidone) used in the synthesis of the colloid at the same concentration. At a concentration of 10 μg/mL, a colloidal solution with silver nanoparticles has been found to possess bactericidal activity against two isolates of P. aeruginosa, three isolates of A. baumanii, and five isolates of E. coli. At a concentration of 1 μg/mL, the colloidal solution of silver nanoparticles has possessed only bacteriostatic activity against all isolates of the bacteria. The minimum bacteriostatic inhibitory concentration of nanosilver has determined to be 3 μg/mL. © 2016, Pleiades Publishing, Ltd.
引用
收藏
页码:835 / 841
页数:6
相关论文
共 36 条
[1]  
Andreeva I.V., Stetsyuk O.U., Allergic reactions to antibiotics, Klin. Farmakol. Terap., 22, 2, pp. 5-10, (2013)
[2]  
Baranov V.Y., Frolov V.I., Electrokinetic Phenomena, The School-Book, (2007)
[3]  
Basov A.A., Malyshko V.V., Fedosov S.R., Savchenko Y.P., Vlasov R.V., Chernobai K.N., Device for silver nanoparticle production, (2015)
[4]  
Blinov A.V., Blinova A.A., Serov A.V., Khramtsov A.G., Naberezhnyi D.O., Study of stability of silver nanoparticles concentrate in different media, Proceedings of the 4th International Scientific-Practical Conference on Actual Problems of Modern Science, pp. 393-396, (2015)
[5]  
Vegera A.V., Zimon A.D., Synthesis and physicochemical properties of silver nanoparticles stabilized by gelatin, Izv. Tomsk. Politekh. Univ., 309, 5, pp. 60-63, (2006)
[6]  
Golubeva O.Y., Shamova O.V., Orlov D.S., Pazina T.Y., Boldina A.S., Drozdova I.A., Kokryakov V.N., Synthesis and study of antimicrobial activity of bioconjugates of silver nanoparticles and endogenous antibiotics, Glass Phys. Chem., 37, (2011)
[7]  
Zhabaeva S., Osmonkanova G.N., Zhunusov A.B., Study of silver nanosized sol by electron spectroscopy method, Izv. Vyssh. Uchebn. Zaved. Kyrgyzstana, 5, pp. 88-90, (2014)
[8]  
Zolotukhina E.V., Kravchenko T.A., Peshkov S.V., Method of silver nanoparticle production, (2010)
[9]  
Kasanov K.N., Popov V.A., Evseev R.A., Andreev V.A., Vezentsev A.I., Ponomareva N.F., Ignat'eva Y.A., Uspenskaya M.V., Khripunov A.K., Montmorillonite modified by silver: preparation, antimicrobial activity and medical application in bioactive wound coverings, Nauch. Vedom. Belgor. Univ., Ser.: Med. Farm., 23, 18, pp. 188-197, (2013)
[10]  
Koshelev K.K., Kosheleva O.K., Svistunov M.G., Pautov V.P., Production method of concentrates of zero-valence metal nanodispersions with antiseptic properties, (2010)